28153991|t|Sex -Based Differences in Cardiometabolic Biomarkers
28153991|a|Few data are available comparing cardiovascular disease (CVD) biomarker profiles between women and men in the general population. We analyzed sex -based differences in multiple biomarkers reflecting distinct pathophysiological pathways, accounting for differences between women and men in CVD risk factors, body composition, and cardiac morphology. A cross-sectional analysis was performed using data from the Dallas Heart Study, a multiethnic population-based study. Associations between sex and 30 distinct biomarkers representative of 6 pathophysiological categories were evaluated using multivariable linear regression adjusting for age, race, traditional CVD risk factors, kidney function, insulin resistance, MRI and dual-energy x-ray absorptiometry measures of body composition and fat distribution, and left ventricular mass. After excluding participants with CVD, the study population included 3439 individuals, mean age 43 years, 56% women, and 52% black. Significant sex -based differences were seen in multiple categories of biomarkers, including lipids, adipokines, and biomarkers of inflammation, endothelial dysfunction, myocyte injury and stress, and kidney function. In fully adjusted models, women had higher levels of high-density lipoprotein cholesterol and high-density lipoprotein particle concentration, leptin, d-dimer, homoarginine, and N-terminal pro B-type natriuretic peptide, and lower levels of low-density lipoprotein cholesterol, adiponectin, lipoprotein - associated phospholipase A2 mass and activity, monocyte chemoattractant protein-1, soluble endothelial cell adhesion molecule, symmetrical dimethylarginine, asymmetrical dimethylarginine, high-sensitivity troponin T, and cystatin C. Biomarker profiles differ significantly between women and men in the general population. Sex differences were most apparent for biomarkers of adiposity, endothelial dysfunction, inflammatory cell recruitment, and cardiac stress and injury. Future studies are needed to characterize whether pathophysiological processes delineated by these biomarkers contribute to sex -based differences in the development and complications of CVD.
28153991	26	41	Cardiometabolic	T082	UMLS:C3887460
28153991	42	52	Biomarkers	T201	UMLS:C0005516
28153991	86	108	cardiovascular disease	T038	UMLS:C0007222
28153991	110	113	CVD	T038	UMLS:C0007222
28153991	115	124	biomarker	T201	UMLS:C0005516
28153991	142	147	women	T098	UMLS:C0043210
28153991	152	155	men	T098	UMLS:C0025266
28153991	163	181	general population	T098	UMLS:C0683971
28153991	186	194	analyzed	T062	UMLS:C0936012
28153991	230	240	biomarkers	T201	UMLS:C0005516
28153991	325	330	women	T098	UMLS:C0043210
28153991	335	338	men	T098	UMLS:C0025266
28153991	342	345	CVD	T038	UMLS:C0007222
28153991	346	358	risk factors	T033	UMLS:C0035648
28153991	382	389	cardiac	T017	UMLS:C0018787
28153991	404	428	cross-sectional analysis	T062	UMLS:C0010362
28153991	463	481	Dallas Heart Study	T062	UMLS:C0681876
28153991	485	519	multiethnic population-based study	T062	UMLS:C0681876
28153991	562	572	biomarkers	T201	UMLS:C0005516
28153991	612	622	categories	T170	UMLS:C0683312
28153991	628	637	evaluated	T058	UMLS:C0220825
28153991	695	699	race	T098	UMLS:C0034510
28153991	713	716	CVD	T038	UMLS:C0007222
28153991	717	729	risk factors	T033	UMLS:C0035648
28153991	731	746	kidney function	T038	UMLS:C0232804
28153991	748	766	insulin resistance	T038	UMLS:C0021655
28153991	768	771	MRI	T058	UMLS:C0024485
28153991	776	808	dual-energy x-ray absorptiometry	T058	UMLS:C1510486
28153991	842	858	fat distribution	T033	UMLS:C0424621
28153991	864	885	left ventricular mass	T033	UMLS:C0455825
28153991	903	915	participants	T098	UMLS:C0679646
28153991	921	924	CVD	T038	UMLS:C0007222
28153991	930	946	study population	T098	UMLS:C2348561
28153991	961	972	individuals	T098	UMLS:C0027361
28153991	997	1002	women	T098	UMLS:C0043210
28153991	1012	1017	black	T098	UMLS:C0005680
28153991	1076	1086	categories	T170	UMLS:C0683312
28153991	1090	1100	biomarkers	T201	UMLS:C0005516
28153991	1112	1118	lipids	T103	UMLS:C0023779
28153991	1120	1130	adipokines	T103	UMLS:C1955907
28153991	1136	1146	biomarkers	T201	UMLS:C0005516
28153991	1150	1162	inflammation	T038	UMLS:C0021368
28153991	1164	1187	endothelial dysfunction	T038	UMLS:C0856169
28153991	1189	1196	myocyte	T017	UMLS:C0596981
28153991	1208	1214	stress	T038	UMLS:C1516360
28153991	1220	1235	kidney function	T038	UMLS:C0232804
28153991	1263	1268	women	T098	UMLS:C0043210
28153991	1290	1326	high-density lipoprotein cholesterol	T103	UMLS:C0023822
28153991	1331	1364	high-density lipoprotein particle	T103	UMLS:C0023821
28153991	1380	1386	leptin	T103	UMLS:C0299583
28153991	1388	1395	d-dimer	T103	UMLS:C0060323
28153991	1397	1409	homoarginine	T103	UMLS:C0019877
28153991	1415	1456	N-terminal pro B-type natriuretic peptide	T103	UMLS:C0754710
28153991	1478	1513	low-density lipoprotein cholesterol	T103	UMLS:C0023824
28153991	1515	1526	adiponectin	T103	UMLS:C0389071
28153991	1528	1539	lipoprotein	T103	UMLS:C0023820
28153991	1553	1569	phospholipase A2	T103	UMLS:C0031667
28153991	1579	1587	activity	T038	UMLS:C0243102
28153991	1589	1623	monocyte chemoattractant protein-1	T103	UMLS:C0128897
28153991	1633	1667	endothelial cell adhesion molecule	T103	UMLS:C3253526
28153991	1669	1680	symmetrical	T033	UMLS:C0332516
28153991	1681	1697	dimethylarginine	T103	UMLS:C1453836
28153991	1699	1711	asymmetrical	T082	UMLS:C0332514
28153991	1712	1728	dimethylarginine	T103	UMLS:C1453836
28153991	1747	1757	troponin T	T103	UMLS:C0077404
28153991	1763	1773	cystatin C	T103	UMLS:C0071744
28153991	1775	1784	Biomarker	T201	UMLS:C0005516
28153991	1823	1828	women	T098	UMLS:C0043210
28153991	1833	1836	men	T098	UMLS:C0025266
28153991	1844	1862	general population	T098	UMLS:C0683971
28153991	1903	1913	biomarkers	T201	UMLS:C0005516
28153991	1928	1951	endothelial dysfunction	T038	UMLS:C0856169
28153991	1953	1982	inflammatory cell recruitment	T033	UMLS:C0243095
28153991	1988	2002	cardiac stress	T033	UMLS:C2317276
28153991	2007	2013	injury	T037	UMLS:C0018805
28153991	2114	2124	biomarkers	T201	UMLS:C0005516
28153991	2185	2198	complications	T038	UMLS:C0009566
28153991	2202	2205	CVD	T038	UMLS:C0007222